Bio-Thera Solutions Ltd (SHG:688177) — Stock Price
Bio-Thera Solutions Ltd (SHG:688177) is currently trading at CN¥19.43 CNY, up 4.74% today. Over the past 52 weeks, shares have ranged between CN¥16.10 and CN¥34.72. This page tracks Bio-Thera Solutions Ltd's live share price on the SHG exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Bio-Thera Solutions Ltd stock valuation.
Bio-Thera Solutions Ltd (688177) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Bio-Thera Solutions Ltd's daily closing share price and trading volume on the SHG exchange over the past year, giving a clear view of recent price momentum and liquidity.
Bio-Thera Solutions Ltd Income Statement — Revenue, Profit & Earnings by Year
Bio-Thera Solutions Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | CN¥935.22 Million | CN¥743.17 Million | CN¥704.79 Million | CN¥455.13 Million | CN¥836.58 Million |
| Cost of Revenue | CN¥197.22 Million | CN¥229.54 Million | CN¥193.30 Million | CN¥190.62 Million | CN¥35.60 Million |
| Gross Profit | CN¥738.00 Million | CN¥513.62 Million | CN¥511.50 Million | CN¥264.51 Million | CN¥800.98 Million |
| Research & Development | CN¥800.15 Million | CN¥777.63 Million | CN¥768.64 Million | CN¥616.39 Million | CN¥543.42 Million |
| SG&A | CN¥273.32 Million | CN¥215.52 Million | CN¥102.83 Million | CN¥153.73 Million | CN¥194.38 Million |
| Total Operating Expenses | CN¥1.28 Billion | CN¥1.24 Billion | CN¥1.10 Billion | CN¥949.78 Million | CN¥752.32 Million |
| Operating Income | CN¥-346.27 Million | CN¥-496.02 Million | CN¥-392.55 Million | CN¥-494.64 Million | CN¥84.26 Million |
| EBITDA | — | — | — | CN¥-396.50 Million | CN¥164.76 Million |
| EBIT | — | — | — | CN¥-494.64 Million | CN¥84.26 Million |
| Interest Expense | CN¥20.07 Million | CN¥20.55 Million | CN¥10.38 Million | CN¥61.93K | CN¥775.44K |
| Income Before Tax | CN¥-331.65 Million | CN¥-510.30 Million | CN¥-394.42 Million | CN¥-480.40 Million | CN¥91.04 Million |
| Income Tax Expense | — | — | — | CN¥2.12K | CN¥9.11 Million |
| Net Income | CN¥-331.94 Million | CN¥-510.30 Million | CN¥-394.53 Million | CN¥-480.40 Million | CN¥81.94 Million |
Bio-Thera Solutions Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Bio-Thera Solutions Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | CN¥2.29 Billion | CN¥2.21 Billion | CN¥2.29 Billion | CN¥2.18 Billion | CN¥2.62 Billion |
| Total Current Assets | CN¥958.56 Million | CN¥887.95 Million | CN¥1.01 Billion | CN¥1.16 Billion | CN¥1.77 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | CN¥90.22 Million | CN¥331.03 Million | CN¥629.89 Million | CN¥602.83 Million |
| Net Receivables | CN¥164.70 Million | CN¥104.15 Million | CN¥148.72 Million | CN¥89.75 Million | CN¥103.32 Million |
| Inventory | CN¥312.42 Million | CN¥253.10 Million | CN¥231.23 Million | CN¥161.90 Million | CN¥90.10 Million |
| Property, Plant & Equipment | — | — | — | CN¥693.91 Million | CN¥579.43 Million |
| Goodwill | — | — | — | — | — |
| Total Liabilities | CN¥1.91 Billion | CN¥1.50 Billion | CN¥1.07 Billion | CN¥572.48 Million | CN¥530.27 Million |
| Total Current Liabilities | CN¥1.37 Billion | CN¥1.10 Billion | CN¥725.42 Million | CN¥538.50 Million | CN¥526.04 Million |
| Long-term Debt | CN¥374.21 Million | CN¥370.43 Million | CN¥323.84 Million | CN¥3.00 Million | — |
| Net Debt | CN¥235.68 Million | CN¥169.38 Million | CN¥318.63 Million | — | — |
| Total Stockholder Equity | CN¥376.03 Million | CN¥708.09 Million | CN¥1.21 Billion | CN¥1.61 Billion | CN¥2.09 Billion |
| Retained Earnings | CN¥-3.09 Billion | CN¥-2.77 Billion | CN¥-2.26 Billion | CN¥-1.86 Billion | CN¥-1.38 Billion |
Bio-Thera Solutions Ltd Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Bio-Thera Solutions Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | CN¥-82.11 Million | CN¥-55.65 Million | CN¥-460.87 Million | CN¥-412.82 Million | CN¥236.27 Million |
| Capital Expenditures | CN¥121.74 Million | CN¥126.85 Million | CN¥275.86 Million | CN¥258.82 Million | CN¥77.89 Million |
| Free Cash Flow | CN¥-203.86 Million | CN¥-182.50 Million | CN¥-780.25 Million | CN¥-671.64 Million | CN¥158.38 Million |
| Investing Cash Flow | — | — | — | CN¥-245.80 Million | CN¥301.76 Million |
| Financing Cash Flow | — | — | — | CN¥-30.15 Million | CN¥26.54 Million |
| Dividends Paid | CN¥20.39 Million | CN¥20.60 Million | CN¥5.67 Million | CN¥164.50K | CN¥553.00K |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | CN¥104.31 Million | CN¥89.39 Million | CN¥85.24 Million | CN¥83.84 Million | CN¥72.94 Million |
| Change in Cash | CN¥-50.10 Million | CN¥150.88 Million | CN¥169.35 Million | CN¥-688.00 Million | CN¥563.77 Million |
Bio-Thera Solutions Ltd Earnings History — EPS Actual vs. Analyst Estimates
Track Bio-Thera Solutions Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Apr 18, 2025 | — | — | — |
| Mar 31, 2023 | -0.34 | — | — |
| Dec 31, 2022 | -0.54 | — | — |
| Sep 30, 2022 | -0.21 | — | — |
| Jun 30, 2022 | -0.14 | — | — |
| Apr 29, 2022 | -0.27 | — | — |
| Mar 04, 2022 | 0.47 | — | — |
| Oct 29, 2021 | -0.28 | — | — |